News | Holter Monitoring Systems | October 25, 2022

RhythMedix Expands Monitoring Capabilities of Its RhythmStar System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity

Strategic addition of Extended Wear Holter monitoring modality enhances portfolio offering and positions company for accelerated growth

CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.

October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms, today announced expanded modalities for its RhythmStar System (RhythmStar). The addition of long-term continuous electrocardiogram (ECG) monitoring up to 14 days provides clinicians with a complete and flexible cardiac monitoring solution, with rapid report turnaround in less than 48 hours, to address a diverse range of patient needs. 

"We are especially pleased to launch expanded capabilities so close to National AFib Awareness Month. Early arrhythmia detection is critical. RhythMedix is committed to transforming and simplifying the diagnostic pathway to enable faster diagnosis, without missing a beat," stated Brian Pike, President, of RhythMedix. "We've monitored over 1 million patients and look forward to accelerating adoption of our innovative remote cardiac monitoring solution to reach even more patients." 

Alternative monitoring systems require patients to send the wearable device back to the manufacturer for manual data retrieval, analysis and report generation. Unlike these systems, RhythmStar instantly transfers data wirelessly to enable faster ECG analysis with rapid report turnaround, so that care providers receive diagnostic reporting weeks faster than with mail back data retrieval methods. The RhythmStar platform fits seamlessly into clinical practice and its interoperability support easily integrates with electronic medical record (EMR) systems. In addition to the new Extended Wear Holter option, RhythMedix offers multiple modalities including mobile cardiac telemetry. 

Heart arrhythmias are a major health concern and double the risk of death in an estimated 37.5 million people worldwide. Atrial fibrillation (AFib) is the most frequent cardiac arrhythmia and a major risk factor for ischemic stroke.1,2 While remote cardiac monitoring has improved arrhythmia detection, patient compliance and timely access to heart activity remain a challenge with currently available competitive monitoring technologies. 

Since the launch of its next-generation RhythmStar System last year, the company is experiencing tremendous near 30% year-over-year growth and has more than doubled adoption of its platform by cardiologists, electrophysiologists, and healthcare systems across the United States. The sleek, patient-friendly device is the first one-piece, wearable cardiac monitor with built-in cellular connectivity. This novel feature enables near real-time arrhythmia verification without the need for a separate communication device, making it simpler for the patient and clinician while maximizing patient compliance. 

For more information: www.rhythmedix.com 

References: 

 

https://www.ajconline.org/article/S0002-9149(98)00583-9/fulltext

https://journals.sagepub.com/doi/10.1177/1747493019897870


Related Content

News | ECG

May 24, 2023 — Rhythm Technologies, Inc., a leading digital health care company focused on creating trusted solutions ...

Home May 24, 2023
Home
News | ECG

May 9, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...

Home May 09, 2023
Home
News | ECG

April 5, 2023 — Sharing, viewing and storing ECG data into PACS and EMR systems has been a struggle for may institutions ...

Home April 05, 2023
Home
News | ECG

March 27, 2023 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ...

Home March 27, 2023
Home
News | ECG

March 13, 2023 — iRhythm Technologies, Inc., a leading digital health company focused on creating trusted solutions that ...

Home March 13, 2023
Home
News | ECG

December 26, 2022 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...

Home December 26, 2022
Home
News | ECG

December 1, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving ...

Home December 01, 2022
Home
News | ECG

October 28, 2022 — Heart Test Laboratories, Inc., a medical technology company focused on saving lives by making an ECG ...

Home October 28, 2022
Home
News | ECG

October 19, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving ...

Home October 19, 2022
Home
News | ECG

September 29, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

Home September 29, 2022
Home
Subscribe Now